Home Authors Posts by Tess Egginton

Tess Egginton

Tess Egginton
1438 POSTS 0 COMMENTS

News

Merck opens $1bn facility to increase vaccine production capacity

Merck (known as MSD outside of the United States and Canada) has opened a new, $1 billion, 225,000 sq ft facility dedicated to vaccine...

Ono enters license agreement with Ionis for polycythemia vera treatment sapablursen

Ono Pharmaceutical has entered into a license agreement with Ionis Pharmaceuticals for sapablursen, an investigational RNA-targeted medicine for the treatment of polycythemia vera (PV). Sapablursen...

ONCOVITA and UNITHER Pharmaceuticals to develop new prophylactic vaccine based on Measovir and Euroject...

ONCOVITA, a biotechnology company specializing in innovative vaccine development and a spin-off from the Institut Pasteur, and UNITHER Pharmaceuticals, a global leader in sterile...